awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33588346-32CF3AFD-844C-4EFE-B05A-262598499368
Q33588346-32CF3AFD-844C-4EFE-B05A-262598499368
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33588346-32CF3AFD-844C-4EFE-B05A-262598499368
Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain
P2860
Q33588346-32CF3AFD-844C-4EFE-B05A-262598499368
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33588346-32CF3AFD-844C-4EFE-B05A-262598499368
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5eb72ba7d0d6fa1c44c64be34ef7bd9c6354b140
P2860
Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study.